Longevity & AgingCancer Deaths Keep Falling as New Treatments, Diabetes Links, and Vitamin C Data Reshape Oncology
U.S. cancer deaths continued declining from 2019 to 2023, driven mainly by fewer lung cancer fatalities, even as overall cancer cases rose. Key findings from the latest research roundup include a striking statistic that people with type 2 diabetes face double the cancer risk of those without the condition. Vitamin C supplements show early promise in preventing myeloid malignancies in patients with precancerous blood disorders. A combination immunotherapy regimen for multiple myeloma produced survival rates approaching those of an age-matched healthy population. Physical activity, especially walking, was linked to less fatigue in colorectal cancer survivors. Novel drug delivery systems and new FDA approvals round out a busy week of oncology news, highlighting both progress and persistent challenges in cancer prevention and treatment.
